相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunomodulation of Tumor Microenvironment by Arginine-Loaded Iron Oxide Nanoparticles for Gaseous Immunotherapy
Xiaqing Wu et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
Modulation of tumor microenvironment using a TLR-7/8 agonist-loaded nanoparticle system that exerts low-temperature hyperthermia and immunotherapy for in situ cancer vaccination
Po-Ming Chen et al.
BIOMATERIALS (2020)
Clinical application of immune checkpoints in targeted immunotherapy of prostate cancer
Sevda Jafari et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Immunotherapy-based combination strategies for advanced urothelial cancer: A long quest
Ali Raza Khaki et al.
CANCER (2020)
Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis
James C. Lee et al.
SCIENCE IMMUNOLOGY (2020)
Multifunctional Nanoparticles Boost Cancer Immunotherapy Based on Modulating the Immunosuppressive Tumor Microenvironment
Ji Li et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Tumor mutational burden (TMB) and response rates to immune checkpoint inhibitors (ICIs) targeting PD-1, CTLA-4, and combination.
Arsen Osipov et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Response rate to chemotherapy after disease progression with anti-PD-1/PD-L1 in metastatic cancer.
Munaf Al-Kadhimi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
839 Dual targeting autoinflammation and PD-L1/L2 immune checkpoint by EGCG augments anti-tumor effects in melanoma
Y. Li et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Cancer nanomedicine for combination cancer immunotherapy
Jutaek Nam et al.
NATURE REVIEWS MATERIALS (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
Engineering nanoparticles to locally activate T cells in the tumor microenvironment
Dangge Wang et al.
SCIENCE IMMUNOLOGY (2019)
T Regulatory Cells and Priming the Suppressive Tumor Microenvironment
Christina M. Paluskievicz et al.
FRONTIERS IN IMMUNOLOGY (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Emerging Nano-/Microapproaches for Cancer Immunotherapy
Yu Mi et al.
ADVANCED SCIENCE (2019)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
OX40 Costimulation Inhibits Foxp3 Expression and Treg Induction via BATF3-Dependent and Independent Mechanisms
Xiaolong Zhang et al.
CELL REPORTS (2018)
Identifying and managing the adverse effects of immune checkpoint blockade
Arthur Winer et al.
JOURNAL OF THORACIC DISEASE (2018)
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors A Systematic Review and Meta-analysis
Daniel Y. Wang et al.
JAMA ONCOLOGY (2018)
Developing combination immunotherapies against cancer that make sense
Andre Veillette et al.
SCIENCE IMMUNOLOGY (2018)
Comparison of the Toxicity Profile of PD-1 Versus PD-L1 Inhibitors in Non-Small Cell Lung Cancer: A Systematic Analysis of the Literature
Rathi N. Pillai et al.
CANCER (2018)
Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8(+) T cell dysfunction and maintain memory phenotype
Bei Wang et al.
SCIENCE IMMUNOLOGY (2018)
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai et al.
NATURE MATERIALS (2017)
Tumor Microenvironment Responsive Nanogel for the Combinatorial Antitumor Effect of Chemotherapy and Immunotherapy
Qingle Song et al.
NANO LETTERS (2017)
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
Daniela Schmid et al.
NATURE COMMUNICATIONS (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
Rationale for anti-OX40 cancer immunotherapy
Sandrine Aspeslagh et al.
EUROPEAN JOURNAL OF CANCER (2016)
CTLA-4 and PD-1 pathway blockade: combinations in the clinic
Margaret K. Callahan et al.
FRONTIERS IN ONCOLOGY (2015)
Antibodies Targeting Human OX40 Expand Effector T Cells and Block Inducible and Natural Regulatory T Cell Function
Kui S. Voo et al.
JOURNAL OF IMMUNOLOGY (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Degradable Thermoresponsive Nanogels for Protein Encapsulation and Controlled Release
Neha Bhuchar et al.
BIOCONJUGATE CHEMISTRY (2012)
The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation
Holger Hackstein et al.
CELLULAR IMMUNOLOGY (2011)
Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro
C Blank et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
分享论文
